Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    " August 22, 2007":" September 21, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV
Conditions: Genital Herpes;   HIV Infection
Interventions: Drug: valacyclovir;   Drug: acyclovir
22 Completed
Has Results
A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Condition: Human Immunodeficiency Virus - Type 1
Interventions: Drug: Darunavir (DRV);   Drug: Ritonavir (rtv)
23 Terminated Randomized Clinical Trial to Assess the Efficacy and Safety of Concomitant Use of Rifampicin and Efavirenz 600 X 800mg
Conditions: Tuberculosis;   HIV Infections
Intervention: Drug: efavirenz
24 Completed Raltegravir Insulin Sensitivity Study
Condition: HIV Infections
Interventions: Drug: Raltegravir then lopinavir/ritonavir;   Drug: Lopinavir/ritonavir then raltegravir
25 Completed TMC 125 Blood Levels Study
Condition: HIV Infections
Interventions: Drug: TMC125 once daily;   Drug: TMC125 twice daily
26 Completed
Has Results
Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Ritonavir
27 Completed
Has Results
Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients
Condition: HIV Infections
Interventions: Drug: tipranavir;   Drug: ritonavir
28 Completed
Has Results
Evaluating the Effect of CHanging EnfuvirtidE to Raltegravir in HIV Infected Subjects
Condition: HIV Infections
Intervention: Drug: raltegravir
29 Completed Switching From PI to RALtegravir in HIV Stable Patients
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: boosted PI
30 Completed
Has Results
RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir
31 Completed Evaluation of Albuminuria HIV-Infected Patients
Conditions: HIV-Associated Focal Segmental Glomerulosclerosis;   HIV-Associated Collapsing Glomerulopathy;   Proteinuria;   Albuminuria;   Renal Tubular Toxicity
32 Completed
Has Results
A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).
Condition: HIV-1 Infection
Intervention: Drug: TMC125; darunavir; ritonavir

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Indicates status has not been verified in more than two years